Location History:
- Osaka, JP (2008)
- Tokyo, JP (2011)
- Chuo-ku, JP (2011)
Company Filing History:
Years Active: 2008-2011
Title: Susumu Toda: Innovator in Pharmaceutical Chemistry
Introduction
Susumu Toda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors associated with various medical conditions. With a total of 3 patents to his name, his work continues to impact the medical community.
Latest Patents
One of Toda's latest patents involves a sulfonamide compound or salt thereof. This compound is designed to treat diseases associated with the EP1 receptor, specifically targeting lower urinary tract symptoms. The invention highlights a sulfonamide compound characterized by a unique chemical structure that exhibits potent EP1 receptor antagonistic activity. This discovery is crucial for developing effective treatments for patients suffering from related conditions.
Another notable patent from Toda focuses on aminoalcohol derivatives. This invention presents a compound formula that offers therapeutic benefits for conditions such as ulcers and overactive bladder. The detailed chemical structure and potential applications of these compounds underscore Toda's innovative approach to pharmaceutical development.
Career Highlights
Toda is currently affiliated with Astellas Pharma GmbH, where he continues to advance his research and development efforts. His work at Astellas Pharma has positioned him as a key player in the pharmaceutical industry, contributing to the creation of effective therapeutic agents.
Collaborations
Throughout his career, Toda has collaborated with esteemed colleagues, including Kouji Hattori and Shinji Ito. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in pharmaceutical chemistry.
Conclusion
Susumu Toda's contributions to the field of pharmaceutical chemistry are noteworthy, with his innovative patents addressing critical medical needs. His ongoing work at Astellas Pharma and collaborations with fellow researchers continue to pave the way for advancements in treatment options.